Subscribe to our Newsletters !!
How are viruses different from bacteria apex ? O
Pharmaceutical laboratories have been adopting imm
Generally, a debate about Isopure protein and regu
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
Seasonal torrential rains and dark and thick vegetation and some other culture thronging upon the possible livelihood in these regions will encounter the wrath of the several vectors (carriers) which bring a myriad of ailments. The easy to go approach of dealing these endemics was to kill the vectors and then if it reached the epidemic proportions, there is demand for disaster management and vector control mitigation steps and improved treatment required at the center-stage.
Since ancient times, India was listed as one of The hard hit regions with vector borne diseases with the maximum mortality ranging from Malaria, Dengue and now Chikungunya. A recent study showed that till the last ten years, India simply shared the greatest burden of Malaria led mortality in 20%. The mid 2000s gave the first glimpse of Dengue and Chikungunya epidemics which paralyzed the health setup of the country. Initially Scientists were divided in their approaches that could make the best impact in controlling the diseases. The idea therefore embraced was to initiate a nationwide eradication program (for vector borne diseases initially, which was later segregated into Malaria and Dengue-Chikungunya respectively), effective vector control methods with close monitoring throughout the monsoons (Insecticide induced Mosquito nets, Fumigation clusters etc.) and early detection and identification for therapy (testing on Rapid Cards, and subsequently management of Drug cocktail to get ideal drug delivery system).
NVBDCP was listed as the sole governing body who’d initiate the yearly programs and execute the strategies to maintain the diseases under control. Thanks to the global initiatives like BIRAC, Bill and Melinda Gates Foundation, WHO and Clinton Foundation, not only the overall populace has become aware of the hygienic lifestyle and enhanced living conditions but also a innovative approach to vector control and improved and reasonably priced access to precise and early diagnosis for the illness has retained the vectors at bay and apparently there has been no epidemic (not even in endemic proportions) since 2015.
J Mitra & Co. has been a pioneer in the field of rapid and reliable diagnostic solutions since the last five decades and has been addressing the constant changes in diagnosis of vector borne diseases with the introduction of Rapid Test Cards by using special proteins and markers specific to the Indian population, followed by ELISA kits and now to Fluorescence Immunoassays. For routine, affordable mode of testing in vast population, Rapid cards like Malcard, Advantage Malaria card and Dengue Day-1 cards are in place which are the market leader. ELISA kits for Dengue and Chikungunya have been trendsetter for market and their performance has challenged the higher platforms even for transient infections. The company has forayed in FIA domain with the introduction of indigenously developed and evolved (with collaboration of IIT, Madras) Quanti Dengue Cards (for NS1, IgG and IgM) which are clinically at par with PCR tests.
